Biotech · Private company
Zealand Pharma
Track this companyFree. Adds Zealand Pharma to your Dealase workspace and tells you when its record changes.
Clinical trials195 recruiting or active
Pipeline programs13From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline13
- dasiglucagonPhase 3 · Congenital HyperinsulinismClinicalTrials.gov · fetched Nov 12, 2026
- DasiglucagonPhase 3 · HypoglycemiaClinicalTrials.gov · fetched Nov 12, 2026
- GlepaglutidePhase 3 · Short Bowel SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- Glepaglutide 10 mgPhase 3 · Short Bowel Syndrome (SBS)ClinicalTrials.gov · fetched Nov 12, 2026
- GlucaGenPhase 3 · HypoglycemiaClinicalTrials.gov · fetched Nov 12, 2026
- GlucaGen HypoKitPhase 3 · HypoglycemiaClinicalTrials.gov · fetched Nov 12, 2026
- GlucagonPhase 2 · Diabetes Mellitus, Type 1ClinicalTrials.gov · fetched Nov 12, 2026
- iLet-based bionic pancreasPhase 2 · Diabetes Mellitus, Type 1ClinicalTrials.gov · fetched Nov 12, 2026
- Insulin LisproPhase 2 · Diabetes Mellitus, Type 1ClinicalTrials.gov · fetched Nov 12, 2026
- iPhone-based bionic pancreasPhase 2 · Diabetes Mellitus, Type 1ClinicalTrials.gov · fetched Nov 12, 2026
- PetrelintidePhase 2 · ObesityClinicalTrials.gov · fetched Nov 12, 2026
- PetrelintidePhase 2 · OverweightClinicalTrials.gov · fetched Nov 12, 2026
- ZP4207 (dasiglucagon)Phase 2 · Diabetes Mellitus, Type 1ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials19
- A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 DiabetesPHASE3 · RECRUITING · started Oct 9, 2026ClinicalTrials.gov NCT07843485 · fetched Nov 12, 2026
- A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or ObesityPHASE3 · RECRUITING · started Sep 30, 2026ClinicalTrials.gov NCT07843498 · fetched Nov 12, 2026
- A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Established Cardiovascular DiseasePHASE3 · RECRUITING · started Sep 30, 2026ClinicalTrials.gov NCT07843472 · fetched Nov 12, 2026
- Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBSPHASE3 · RECRUITING · started Feb 11, 2026ClinicalTrials.gov NCT07197944 · fetched Nov 12, 2026
- Efficacy and Safety Evaluation of Glepaglutide in Treatment of Short Bowel SyndromePHASE3 · ACTIVE_NOT_RECRUITING · started Dec 11, 2025ClinicalTrials.gov NCT07228403 · fetched Nov 12, 2026
- Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)PHASE2 · COMPLETED · started Apr 22, 2025ClinicalTrials.gov NCT06926842 · fetched Nov 12, 2026
- Once-weekly Petrelintide Versus Placebo for Obesity or Overweight With Co-morbiditiesPHASE2 · COMPLETED · started Dec 9, 2024ClinicalTrials.gov NCT06662539 · fetched Nov 12, 2026
- A Study to Inv. Safety, Efficacy & PD of Dasiglucagon as Hypoglycemia Rescue Therapy in Children <6 Years With T1DPHASE3 · COMPLETED · started May 9, 2023ClinicalTrials.gov NCT05378672 · fetched Nov 12, 2026
- Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS - Extension TrialPHASE3 · COMPLETED · started Jun 16, 2021ClinicalTrials.gov NCT04881825 · fetched Nov 12, 2026
- Trial Evaluating Efficacy and Safety of Dasiglucagon in Children With Congenital HyperinsulinismPHASE2_PHASE3 · COMPLETED · started Jun 19, 2020ClinicalTrials.gov NCT04172441 · fetched Nov 12, 2026
- Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBSPHASE3 · COMPLETED · started May 7, 2019ClinicalTrials.gov NCT03905707 · fetched Nov 12, 2026
- Extension Trial Evaluating the Long-term Safety and Efficacy of Dasiglucagon in Children With Congenital HyperinsulinismPHASE3 · COMPLETED · started May 2, 2019ClinicalTrials.gov NCT03941236 · fetched Nov 12, 2026
- A Two-Period Open-label Trial Evaluating Efficacy and Safety of Dasiglucagon in Children With Congenital HyperinsulinismPHASE3 · COMPLETED · started Feb 7, 2019ClinicalTrials.gov NCT03777176 · fetched Nov 12, 2026
- Trial to Confirm the Clinical Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Subjects With T1DMPHASE3 · COMPLETED · started Nov 1, 2018ClinicalTrials.gov NCT03688711 · fetched Nov 12, 2026
- Efficacy And Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome (SBS)PHASE3 · COMPLETED · started Oct 4, 2018ClinicalTrials.gov NCT03690206 · fetched Nov 12, 2026
- Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in T1DM ChildrenPHASE3 · COMPLETED · started Sep 28, 2018ClinicalTrials.gov NCT03667053 · fetched Nov 12, 2026
- A Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Type 1 Diabetes SubjectsPHASE3 · COMPLETED · started Dec 7, 2017ClinicalTrials.gov NCT03378635 · fetched Nov 12, 2026
- A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes MellitusPHASE3 · COMPLETED · started Jun 28, 2017ClinicalTrials.gov NCT03216226 · fetched Nov 12, 2026
- Feasibility Trial Testing the Bionic Pancreas With ZP4207PHASE2 · COMPLETED · started Nov 1, 2016ClinicalTrials.gov NCT02971228 · fetched Nov 12, 2026